Abstract

Stem-loop I (SL1) located in the 5' untranslated region of the hepatitis C virus (HCV) genome initiates binding to miR-122, a microRNA required for hepatitis HCV replication. However, proteins that bind SL1 remain elusive. In this study, we employed a human proteome microarray, comprised of ∼17,000 individually purified human proteins in full-length, and identified 313 proteins that recognize HCV SL1. Eighty-three of the identified proteins were annotated as liver-expressing proteins, and twelve of which were known to be associated with hepatitis virus. siRNA-induced silencing of eight out of 12 candidate genes led to at least 25% decrease in HCV replication efficiency. In particular, knockdown of heterogeneous nuclear ribonucleoprotein K (hnRNP K) reduced HCV replication in a concentration-dependent manner. Ultra-violet-crosslinking assay also showed that hnRNP K, which functions in pre-mRNA processing and transport, showed the strongest binding to the HCV SL1. We observed that hnRNP K, a nuclear protein, is relocated in the cytoplasm in HCV-expressing cells. Immunoprecipitation of the hnRNP K from Huh7.5 cells stably expressing HCV replicon resulted in the co-immunoprecipitation of SL1. This work identifies a cellular protein that could have an important role in the regulation of HCV RNA gene expression and metabolism.

Highlights

  • RNA viruses are the cause of numerous human diseases

  • To determine whether the bound proteins are specific to SL1, SL3d that is present in the 5Ј UTR of hepatitis C virus (HCV) RNA was used as a control (Fig. 1A and supplemental Fig. S1)

  • Because heterogeneous nuclear ribonucleoprotein K (hnRNP K) exhibited the strongest interactions to the HCV RNA, we further focused on hnRNP K study

Read more

Summary

EXPERIMENTAL PROCEDURES

RNA-binding Assays on the Human Proteome Microarrays—The human proteome microarrays, comprised of more than 17,000 fulllength human proteins with N-terminal GST-fusions, were constructed on the glass-based slides as previously reported [15]. The cover slips were removed and each microarray was washed with 500 ml DEPC-treated PBST (PBS, 0.05% tween-20) for 10 min at 37 °C, on a rotary shaker set at 10 rpm. SiRNA Knockdown Assays—siRNAs (20 nM per reaction) were transfected into Huh7.5 cells harboring the HCV replicon that expresses the Renilla luciferase (RLuc) [18]. The primers used were: HCV 5Ј UTR sense (5Ј-AGC CAT GGC GTT AGT ATG AGT GTC-3Ј) and HCV 5Ј UTR antisense (5Ј-ACA AGG CCT TTC GCG ACC CAA C-3Ј). The change in HCV RNA and ␤-actin mRNA levels in siRNA-treated cells was compared with the mock-transfected control as previously reported [19]. HCV 5Ј-UTR sense (5Ј-AGC CAT GGC GTT AGT ATG AGT GTC-3Ј) and 5Ј-UTR antisense (5Ј- ACA AGG CCT TTC GCG ACC CAA C-3Ј) primers were used to amplify HCV 5Ј UTR-specific sequences. Quantification of the number of copies of the HCV RNA has been described previously [22]

RESULTS
DISCUSSION
16. Deleted in proof
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call